Invention Grant
US09126959B2 PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases
有权
用于治疗代谢疾病的PPAR保留噻唑烷二酮盐
- Patent Title: PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases
- Patent Title (中): 用于治疗代谢疾病的PPAR保留噻唑烷二酮盐
-
Application No.: US14528163Application Date: 2014-10-30
-
Publication No.: US09126959B2Publication Date: 2015-09-08
- Inventor: Gerard R. Colca , Steven P. Tanis , Scott D. Larsen
- Applicant: Metabolic Solutions Development Company, LLC
- Applicant Address: US MI Kalamazoo
- Assignee: Metabolic Solutions Development Company, LLC
- Current Assignee: Metabolic Solutions Development Company, LLC
- Current Assignee Address: US MI Kalamazoo
- Agency: Honigman Miller Schwartz & Cohn LLP
- Agent Andrew N. Weber; Jonathan P. O'Brien
- Main IPC: C07D277/34
- IPC: C07D277/34 ; C07D417/12
Abstract:
The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).
Public/Granted literature
- US20150051406A1 PPAR-SPARING THIAZOLIDINEDIONE SALTS FOR THE TREATMENT OF METABOLIC DISEASES Public/Granted day:2015-02-19
Information query
